Table 4.
Patient group | Poor-prognosis tumors* | Good-prognosis tumors* | ||||||
---|---|---|---|---|---|---|---|---|
Lung carcinoma | Adenocarcinoma | Breast carcinoma | Multiple myeloma | Renal cell carcinoma | Prostate carcinoma | Thyroid carcinoma | All patients | |
n = 26 | n = 5 | n = 23 | n = 22 | n = 19 | n = 9 | n = 5 | n = 138 | |
All patients (n = 138) | 54 (49–61) | 57 (54–63) | 53 (46–63) | 51 (39–62) | 51 (39–63) | 49 (39–51) | 49 (39–51) | 53 (39–61) |
Pathologic fracture | ||||||||
No (n = 100) | 51 (39–57) | 56 (52–30) | 51 (39–61) | 54 (39–63) | 46 (39–57) | 49 (43–53) | 49 (39–51) | 51 (39–57) |
Yes (n = 38) | 61 (53–63) | 74 (74–74) | 57 (51–63) | 50 (46–58) | 66 (63–69) | 39 (39–39) | – | 58 (49–63) |
The most common primary tumor types are included (n > 5); *based on study by Katagiri et al. [17], primary tumors were categorized as tumors with a relatively good prognosis (breast, kidney, prostate, thyroid, myeloma, and lymphoma), and tumors with a relatively poor prognosis (all other tumor types).